<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00490828</url>
  </required_header>
  <id_info>
    <org_study_id>149/00</org_study_id>
    <nct_id>NCT00490828</nct_id>
  </id_info>
  <brief_title>Influence of Hydrocortisone on Immunologic Markers and Health Care Related Quality of Life in Patients After Cardiac Surgery</brief_title>
  <official_title>Influence of Hydrocortisone on Humoral and Cellular Immunologic Markers in High Risk Patients After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hydrocortisone has been shown to improve the early outcome of high risk patients after
      cardiac surgery. A potential mechanism resulting in this effect may be its immunomodulatory
      action. In this prospective interventional study this hypothesis is to be proven.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: Prospective interventional randomized double blind placebo controlled study.

      Intervention: Hydrocortisone in stress doses vs. placebo

      Patients: 92 high risk patients after cardiac surgery

      Measurements: Cytokines, Toll-like receptors, NF kappa B, outcome data, health care related
      quality of life, PTSD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>immunologic markers, health care related quality of life, PTSD</measure>
    <time_frame>one and a half year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>early clinical outcome parameters (LOS in the ICU)</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Systemic Inflammatory Response Syndrome</condition>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stress doses of hydrocortisone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone</intervention_name>
    <description>Hydrocortisone</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
    <other_name>Stress doses of hydrocortisone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Preoperative left ventricular ejection fraction below 39 % duration of the
             extracorporeal circulation more than 97 min

        Exclusion Criteria:

          -  Pregnancy

          -  Severe liver insufficiency

          -  Severe renal insufficiency

          -  Insulin dependent diabetes mellitus

          -  Steroid therapy

          -  Psychiatric disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shananz Azad, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, University of Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2007</study_first_submitted>
  <study_first_submitted_qc>June 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2007</study_first_posted>
  <last_update_submitted>September 2, 2008</last_update_submitted>
  <last_update_submitted_qc>September 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Gustav Schelling</name_title>
    <organization>Ludwig-Maximilians University, Dept. of Anaesthesiology</organization>
  </responsible_party>
  <keyword>Cardiac surgery</keyword>
  <keyword>systemic inflammatory response syndrome</keyword>
  <keyword>health-related quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

